Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Feb
9
2018
THE LATEST: Divestitures of Complex Pipeline Pharmaceutical Products off the Table at the FTC McDermott Will & Emery
Feb
8
2018
NIA Will Hold Webinar on Nanomedicine: Diagnostics and Therapeutics Advancing through Nanotechnology Bergeson & Campbell, P.C.
Feb
8
2018
Letter from U.S. Senators Applies Additional Pressure to DEA to Promulgate “Special Registration” Rules Under the Ryan Haight Act Epstein Becker & Green, P.C.
Feb
8
2018
Diabetes Drug, Victoza, May Have Weight Loss Benefits, but Allegedly Linked to an Increase Risk of Pancreatic Cancer Stark & Stark
Feb
8
2018
Opioids, Employees, and Accommodations: an Employer’s Primer on Confronting the Crisis Stark & Stark
Feb
8
2018
DOJ Attorneys Explain New Cannabis Enforcement Plans at Summit McDermott Will & Emery
Feb
8
2018
House Passes Bill to Ease Menu Labeling Rules Keller and Heckman LLP
Feb
8
2018
Hoffmann-La Roche – Some Broader Implications Covington & Burling LLP
Feb
8
2018
Green Mountain State Now Even More Green: Vermont Legalizes Recreational Marijuana, Provides Protections for Employers Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
7
2018
CMS Encourages Innovation in MA, Asks Part D Plans to Combat Opioid Overuse, and Fine-Tunes Payments McDermott Will & Emery
Feb
7
2018
More Than Peanuts Sentence of Food Company Officials Upheld Morgan, Lewis & Bockius LLP
Feb
7
2018
Colorado Rejects Latest COOL Measure Keller and Heckman LLP
Feb
6
2018
Top International News in Chemical Policy and Regulation: Americas, Middle East, China Bergeson & Campbell, P.C.
Feb
6
2018
EUON Links Nanomaterials Used in Cosmetic Products to Registration Data Bergeson & Campbell, P.C.
Feb
5
2018
FDA Doubles Down on Efforts to Develop Guidance for Clinical Trial Stakeholders Morgan, Lewis & Bockius LLP
Feb
5
2018
Class Certification Denied in Juice Dispute Proskauer Rose LLP
Feb
5
2018
European Commission Publishes Notice on Possible Food Law Implications of Brexit Keller and Heckman LLP
Feb
5
2018
How patents play a role in drug pricing Neal, Gerber & Eisenberg LLP
Feb
5
2018
Additional TTB Tax Act Guidance McDermott Will & Emery
Feb
4
2018
EFSA Publishes Safety Assessment of Selenium Nanoparticles for Use in Active Food Contact Materials Bergeson & Campbell, P.C.
Feb
3
2018
Recent Challenges to the Use of Hair Follicle Drug Testing Heyl, Royster, Voelker & Allen, P.C.
Feb
2
2018
EPA Signs MOA on ESA; Establishes Interagency Working Group Bergeson & Campbell, P.C.
Feb
2
2018
District Court Dismisses TCPA Class Action for Pharmacy Reminder Calls Under "Emergency Purposes" Exception K&L Gates
Feb
2
2018
Process Safety Management, Union Style Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
2
2018
The Opioid Crisis: An Emerging False Claims Act Risk Trend McDermott Will & Emery
Feb
2
2018
Incretin Mimetics Cases See Signs of New Life on Appeal Stark & Stark
Feb
2
2018
FDA Recognizes First Accreditation to Conduct Food Safety Audits Keller and Heckman LLP
Feb
1
2018
FDA Recognizes First Accreditation Body Under Accredited Third-Party Certification Program and Launches Voluntary Qualified Importer Program Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins